The bill aims to enhance diabetes management in Florida schools by allowing school districts and public schools to acquire and maintain a supply of undesignated glucagon for emergency use in treating students experiencing hypoglycemic episodes. It defines key terms such as "authorized health care practitioner," "participating school," and "undesignated glucagon," and establishes protocols for the storage and administration of glucagon. Schools are authorized to enter into agreements with manufacturers or suppliers to obtain glucagon at reduced prices, accept donations, and apply for grants to support these efforts. Additionally, the bill mandates that schools make glucagon available as per a student's diabetes management plan and requires trained personnel to administer it.

The legislation also provides legal protections for school personnel and health care practitioners involved in the administration of glucagon, granting them immunity from civil and criminal liability under certain conditions. It requires immediate notification of emergency services and parental contact following the administration of glucagon. The State Board of Education, in collaboration with the Department of Health, is tasked with adopting rules to implement these provisions effectively. The act is set to take effect on July 1, 2025.

Statutes affected:
H 597 Filed: 1002.20
H 597 c1: 1002.20
H 597 c2: 1002.20
H 597 c3: 1002.20
H 597 er: 1002.20